Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Accomplishments in 2008 in the management of localized gastric cancer.

Literature DB >> 20011565

Accomplishments in 2008 in the management of localized gastric cancer.

Alicia Okines¹, Yung-Jue Bang, David Cunningham.

Abstract

Overview of the Disease ProcessIncidencePrognostic or Predictive FactorsCurrent General Therapy StandardsSurgeryAdjuvant ChemoradiationPerioperative ChemotherapyAdjuvant Oral Fluoropyrimidine MonotherapyAccomplishments in 2008TherapyBiomarkers and Basic ScienceWhat Needs to Be DoneApplications of the AccomplishmentsControversies and DisagreementsSpecial PopulationsCurrent and Future DirectionsComments on ResearchObstacles to Progress.

Entities: Chemical Disease

Year: 2009 PMID： 20011565 PMCID： PMC2791387

Source DB: PubMed Journal: Gastrointest Cancer Res ISSN： 1934-7820

17 in total

1. Chemotherapy in gastric cancer: a review and updated meta-analysis.

Authors: Karl-Gunnar Janunger; Larsolof Hafström; Bengt Glimelius
Journal: Eur J Surg Date: 2002

2. Nodal dissection for patients with gastric cancer: a randomised controlled trial.

Authors: Chew-Wun Wu; Chao A Hsiung; Su-Shun Lo; Mao-Chin Hsieh; Jen-Hao Chen; Anna Fen-Yau Li; Wing-Yiu Lui; Jacqueline Whang-Peng
Journal: Lancet Oncol Date: 2006-04 Impact factor: 41.316

3. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world.

Authors: Farin Kamangar; Graça M Dores; William F Anderson
Journal: J Clin Oncol Date: 2006-05-10 Impact factor: 44.544

Review 4. Gastric cancer: global pattern of the disease and an overview of environmental risk factors.

Authors: D Forman; V J Burley
Journal: Best Pract Res Clin Gastroenterol Date: 2006 Impact factor: 3.043

5. Extended lymph-node dissection for gastric cancer.

Authors: J J Bonenkamp; J Hermans; M Sasako; C J van de Velde; K Welvaart; I Songun; S Meyer; J T Plukker; P Van Elk; H Obertop; D J Gouma; J J van Lanschot; C W Taat; P W de Graaf; M F von Meyenfeldt; H Tilanus
Journal: N Engl J Med Date: 1999-03-25 Impact factor: 91.245

6. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s.

Authors: Henrike E Karim-Kos; Esther de Vries; Isabelle Soerjomataram; Valery Lemmens; Sabine Siesling; Jan Willem W Coebergh
Journal: Eur J Cancer Date: 2008-02-14 Impact factor: 9.162

7. Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.

Authors: Francesco Di Costanzo; Silvia Gasperoni; Luigi Manzione; Giancarlo Bisagni; Roberto Labianca; Stefano Bravi; Enrico Cortesi; Paolo Carlini; Raffaella Bracci; Silverio Tomao; Luca Messerini; Annarosa Arcangeli; Valter Torri; Domenico Bilancia; Irene Floriani; Maurizio Tonato; Angelo Dinota; Gennaro Strafiuso; Enrichetta Corgna; Stella Porrozzi; Corrado Boni; Ermanno Rondini; Alessandro Giunta; Barbara Monzio Compagnoni; Franco Biagioni; Maurizio Cesari; Giuseppe Fornarini; Fabrizio Nelli; Manlio Carboni; Francesco Cognetti; Maria Ruggeri Enzo; Andrea Piga; Adriana Romiti; Alessandra Olivetti; Luigi Masoni; Marinella De Stefanis; Angelo Dalla Mola; Salvatore Camera; Francesco Recchia; Sandro De Filippis; Loreto Scipioni; Sandra Zironi; Gabriele Luppi; Maurizio Italia; Stefano Banducci; Andrea Pisani Leretti; Bruno Massidda; Maria Teresa Ionta; Angelo Nicolosi; Rodolfo Canaletti; Bruno Biscottini; Fausto Grigniani; Federica Di Costanzo; Rossella Rovei; Enrico Croce; Rosalia Carroccio; Germana Gilli; Carla Cavalli; Angelo Olgiati; Umberto Pandolfi; Riccardo Rossetti; Giovanni Natalini; Paolo Foa; Sabina Oldani; Lorenzo Bruno; Stefano Cascinu; Giuseppina Catalano; Vincenzo Catalano; Ferdinando Lungarotti; Antonio Farris; Maria Giuseppina Sarobba; Mario Trignano; Antonio Muscogiuri; Fontana Francavilla; Franco Figoli; Maurizio Leoni; Giorgio Papiani; Gianfranco Orselli; Mauro Antimi; Vincenzo Bellini; Alessandro Cabassi; Antonio Contu; Antonio Pazzola; Mario Frignano; Elena Lastraioli; Matilde Saggese; Diletta Bianchini; Lorenzo Antonuzzo; Micol Mela; Roberta Camisa
Journal: J Natl Cancer Inst Date: 2008-03-11 Impact factor: 13.506

8. Capecitabine and oxaliplatin for advanced esophagogastric cancer.

Authors: David Cunningham; Naureen Starling; Sheela Rao; Timothy Iveson; Marianne Nicolson; Fareeda Coxon; Gary Middleton; Francis Daniel; Jacqueline Oates; Andrew Richard Norman
Journal: N Engl J Med Date: 2008-01-03 Impact factor: 91.245

9. Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer.

Authors: A F C Okines; A R Norman; P McCloud; Y-K Kang; D Cunningham
Journal: Ann Oncol Date: 2009-05-27 Impact factor: 32.976

10. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.

Authors: A Cuschieri; S Weeden; J Fielding; J Bancewicz; J Craven; V Joypaul; M Sydes; P Fayers
Journal: Br J Cancer Date: 1999-03 Impact factor: 7.640

1 in total

1. Characterization of lymph node metastasis and its clinical significance in the surgical treatment of gastric cancer.

Authors: Chao-Hui Zuo; Hailong Xie; Jingshi Liu; Xiao-Xin Qiu; Jin-Guan Lin; Xiao Hua; Ang Qin
Journal: Mol Clin Oncol Date: 2014-06-03

1 in total